Can partnerships with CRDMOs boost biosimilar manufacturing
Intellectual partnerships — Smaller biotech firms as innovation hubs and ESG considerations encouraging sustainable practices in the pharmaceutical industry.
Syngene’s client Panbela announces issuance of new patent in Japan
Indian prowess collaborations propel CRAMS market
Biologics manufacturing: An opportunity to partner with CRDMOs to bring speed, mitigate risks
SARS-CoV-2 variants: A case for expanding mRNA vaccine production globally
Biopharma companies of West approach big Indian CROs & CDMOs for multi-dimensional solutions
How Syngene International’s CFO is balancing current risks with future viability
Artificial Intelligence – a game changer in revolutionizing drug discovery
CEO Spotlight: Jonathan Hunt, MD and CEO, Syngene International Limited